New Clarivate Biopharma Dealmaking Report Reveals Investment Patterns Set to Impact the Future of Medicine
Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023. This year’s...

